The levels of these two NAEs were also significantly inversely correlated with CB1 protein levels that decrease in the endometrial cancer tissue, suggesting that loss of this particular receptor results in increased availability of AEA and PEA in the tissue and subsequently in plasma. The gene discussed is CNR1; the disease is endometrial cancer.